Nasopharyngeal Carcinoma With Skull Base Erosion Cytologic Findings

This Article

Citations


Creative Commons License
Except where otherwise noted, this work is licensed under Creative Commons Attribution-NonCommercial 4.0 International License.

Article Information:


Group: 2012
Subgroup: Volume 14, Issue 8, Aug
Date: August 2012
Type: Case Report
Start Page: 492
End Page: 494

Authors:

  • Negar Azarpira
  • Department of Pathology,Shiraz University of Medical Sciences, Shiraz, IR Iran
  • Musa Taghipour
  • Department of Neurosurgery,Shiraz University of Medical Sciences, Shiraz, IR Iran
  • Masumeh Pourjebely
  • Department of Pathology,Shiraz University of Medical Sciences, Shiraz, IR Iran

      Correspondence:

      Affiliation: Department of Pathology,Shiraz University of Medical Sciences
      City, Province: Shiraz,
      Country: IR Iran
      Tel: +98-7116474331
      Fax:
      E-mail: negarazarpira@yahoo.com

Abstract:


Nasopharyngeal carcinoma (NPC) occurs more frequently in patients with south-east Asian racial backgrounds. This disease may spreads superiorly to the skull base and intracranium followed by skull base destruction. We report a 56 year-old man presented with headache and diplopia. Magnetic resonance imaging (MRI) revealed extension of destructive mass from ethmoid sinus to the parenchyma. Intraoperative touch cytology showed loose syncytial sheets of pleomorphic abnormal epithelial cells, dyskeratotic cells with abnormal chromatin clumping and irregular nuclear outlines, in a necrotic background. These findings were infavor of keratizing squamous cell carcinoma which was confirmed by histopathology. During interpretation of intraoperative imprint cytology of central nervous system tumors, the possibility of local invasive tumors like NPC should be considered.


Please cite this paper as:
Azarpira N, Taghipour M, Pourjebely M. Nasopharyngeal Carcinoma With Skull Base Erosion Cytologic Findings. Iran Red Crescent Med J.2012;14(8):492-4.

Keywords: Nasopharyngeal carcinoma; Cytology; Imprinting (Psychology); Intraoperative Period

Manuscript Body:


1. Introduction

NPC is a rare tumor in many parts of the world, but is prevalent among Southeast Asian. It usually arises from eustachian tube opening in the Rosenmuller fossa. Initial complaints are often due to middle ear obstruction (otitis media or hearing loss) or local invasion (headache and cranial nerve palsy). There are few reports of NPC with diffuse skull base destruction, resulting in obstructive hydrocephalus, cerebellopontine involvement or even cavernous sinus metastasis (1-4). According to WHO classification, this entity is classified as three different entities: keratizing squamous cell carcinoma, non-keratinizing carcinoma and undifferentiated carcinoma (lymphoepithelioma). Keratizing squamous cell carcinoma mainly developed in male adult patients is least radiosensitive and poor prognosis. Genetic factors and EBV infection have been associated with undifferentiated carcinoma (5).

2. Case Report

We report a 56 year-old man presented with headache, dizziness and diplopia for one-month duration. On physical examination third and sixth cranial nerve palsy were detected. Past medical history was not significant. MRI showed a soft tissue mass originates from ethmoid sinus with upward extension to brain parenchyma (Figure 1) (6). The patient underwent surgery with resection of the lesion in the neurosurgery department. Touch preparation and cryosection slides were fixed in alcohol and stained with rapid hematoxylin and eosin (H & E). The cellular smear composed of loose syncytial sheets and clusters of pleomorphic epitheloid cells containing coarse condensated chromatin, irregular nuclear contours, inconspicuous nucleoli with scant keratinized cytoplasm (Figure 2a, 2b). Cytological diagnosis was infavor of keratizing squamous cell carcinoma (5, 7). Histological examination of the resected specimen confirmed the diagnosis (Figure 3).

 


Figure 1. Sagital view in MRI; Nasopharyngeal mass with enhancement after gadolinium injection.

 

Figure 2a. Sagital view in MRI; Nasopharyngeal mass with enhancement after gadolinium injection.

 

Figure 2b. Small single keratized cell in the cluster of atypical cells with coarse condensated chromatin. (H&E ×400)

 

Figure 3. Squamous cell carcinoma with focal evidence of individual cell keratinization. (H&E ×400)

 

3. Discussion

NPC is endemic in Southern China and is associated with Epstein–Barr virus (EBV) as strong aetiological factor. The titre levels of antibodies to EBV immunoglobulin A viral capsid antigen (IgA VCA) and early antigen (IgA EA) have been widely used as screening and diagnostic markers for NPC. Quantitation of EBV DNA viral load using a real-time PCR technique is highly sensitive and specific method for NPC and correlates well with tumor burden. EBV DNA can be used clinically to monitor disease response and recurrence (8, 9). NPC can spread superiorly to the skull base. Cytologically, the differential diagnoses include craniopharyngioma, epidermoid /dermoid cysts Rathke’s cleft cyst. However, the smears of these lesions show sheets of benign transitional or squamoid epithelial cells with a palisade borders as well as wet keratin. There is no evidence of abnormal dyskeratotic cells. These lesions are often cystic and cholesterol crystals or keratin material can often be detected (5, 7, 10). On the other hand, NPC particularly nonkeratinizing undifferentiated form, may mimic inflammatory and lymphoproliferative disorders. However, the cohesive nature of the tumor cells can differentiate NPCs from most lymphomas (5, 7).In our experience, imprint cytology test is a rapid and inexpensive diagnostic test that tissue integrity is well preserved. In interpretation of imprint cytology of central nervous system tumors, the possibility of local invasive tumors such as NPC should be considered. In these cases, careful examination of the nasopharynx is essential for the exclusion of nasopharyngeal undifferentiated carcinoma because of the obvious differences in treatment and prognosis.

Acknowledgment
None declared.
Financial Disclosure
None declared.
Funding/Support
None declared.

References: (10)

  1. Sham JS, Cheung YK, Choy D, Chan FL, Leong L. Cranial nerve involvement and base of the skull erosion in nasopharyngeal carcinoma. Cancer. 1991;68(2):422-6. [PubMed][DOI: 10.1002/1097-0142(19910715)68:2<422::AID-CNCR2820680235>3.0.CO;2-F ]
  2. Wang CJ, Howng SL. Nasopharyngeal carcinoma with skull base invasion and hydrocephalus: a case report. Kaohsiung J Med Sci. 2002;18(11):582-4. [PubMed]
  3. Low WK, Fong KW, Chong VF. Cerebellopontine angle involvement by nasopharyngeal carcinoma. Am J Otol. 2000;21(6):871-6. [PubMed]
  4. de Bree R, Mehta DM, Snow GB, Quak JJ. Intracranial metastases in patients with squamous cell carcinoma of the head and neck. Otolaryngol Head Neck Surg. 2001;124(2):217-21. [PubMed][DOI: 10.1067/mhn.2001.112478 ]
  5. Tsou MH, Wu ML, Chuang AY, Lin CY, Terng SD. Nasopharyngeal biopsy imprint cytology: a retrospective analysis of 191 cases. Diagn Cytopathol. 2006;34(3):204-7. [PubMed][DOI: 10.1002/dc.20428 ]
  6. Chong VF, Fan YF, Khoo JB. Nasopharyngeal carcinoma with intracranial spread: CT and MR characteristics. J Comput Assist Tomogr. 1996;20(4):563-9. [PubMed][DOI: 10.1097/00004728-199607000-00012 ]
  7. Chao TY, Chiou WY, Liang JG, Tsao TY. Imprint cytology of nasopharyngeal biopsies. Acta Cytol. 1996;40(6):1221-6. [PubMed][DOI: 10.1159/000333984 ]
  8. Wang WY, Twu CW, Lin WY, Jiang RS, Liang KL, Chen KW, et al. Plasma Epstein-Barr virus DNA screening followed by (1)(8)F-fluoro-2-deoxy-D-glucose positron emission tomography in detecting posttreatment failures of nasopharyngeal carcinoma. Cancer. 2011;117(19):4452-9. [PubMed][DOI: 10.1002/cncr.26069 ]
  9. Morris MA, Dawson CW, Young LS. Role of the Epstein-Barr virus-encoded latent membrane protein-1, LMP1, in the pathogenesis of nasopharyngeal carcinoma. Future Oncol. 2009;5(6):811-25. [PubMed][DOI: 10.2217/fon.09.53 ]
  10. Smith AR, Elsheikh TM, Silverman JF. Intraoperative cytologic diagnosis of suprasellar and sellar cystic lesions. Diagn Cytopathol. 1999;20(3):137-47. [PubMed][DOI: 10.1002/(SICI)1097-0339(199903)20:3<137::AID-DC5>3.0.CO;2-K]